The total return over the past 12 months is +27.03% vs. +16.94% for the S&P 500. So far it's up +43.56% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +27.03% | (13.13%) | (6.98%) | N/A | N/A | N/A |
| Total Return CAGR | +27.03% | (13.13%) | (6.98%) | N/A | N/A | N/A |
| Revenue CAGR | (76.20%) | +99.80% | (62.76%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Ovid Therapeutics Inc. (OVID)
| Year | Start price | End price | OVID Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.63 | $2.34 | +43.56% | +14.51% | +29.05% |
| 2025 | $0.93 | $1.63 | +74.57% | +17.72% | +56.85% |
| 2024 | $3.22 | $0.93 | (71.00%) | +24.89% | (95.89%) |
| 2023 | $1.86 | $3.22 | +73.12% | +26.19% | +46.93% |
| 2022 | $3.21 | $1.86 | (42.06%) | (18.17%) | (23.89%) |
| 2021 | $2.31 | $3.21 | +38.96% | +28.74% | +10.22% |
| 2020 | $4.15 | $2.31 | (44.34%) | +18.37% | (62.71%) |
| 2019 | $2.42 | $4.15 | +71.49% | +31.22% | +40.27% |
| 2018 | $9.87 | $2.42 | (75.48%) | (4.56%) | (70.92%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
